NUCLEIC ACID INSIGHTS

February 2026 Issue

Volume 3 Issue 1

Nucleic Acid Insights Volume 3 Issue 1
Download PDF

Featuring

Issue Spotlight: Preclinical and translational tools and tech
Oligonucleotides focus: Oligonucleotide analytics
Other articles
Webinar

SPOTLIGHT

Preclinical and translational tools and tech

Review

Reaching the CNS with therapeutic oligonucleotides via TfR1: navigating delivery and distribution challenges

Reaching the CNS with therapeutic oligonucleotides via TfR1: navigating delivery and distribution challenges

S Zanotti, S Martinez-Montero, S Santos Correia et al.
23 February
Read

Interview

Exploring multifunctional design-for-delivery approaches for nucleic acid therapeutics

Exploring multifunctional design-for-delivery approaches for nucleic acid therapeutics

Sasha Ebrahimi
17 February
Read

Oligonucleotides FOCUS

Oligonucleotide analytics

Review

Oligonucleotide impurity profiling by liquid chromatography–mass spectrometry

Oligonucleotide impurity profiling by liquid chromatography–mass spectrometry

Huijun Tian, Hagen Cramer
11 February
Read

Viewpoint

Guide RNAs in CRISPR-based therapeutics: addressing CMC and analytical challenges to improve clinical translation

Guide RNAs in CRISPR-based therapeutics: addressing CMC and analytical challenges to improve clinical translation

Kok-Seong Lim
30 January
Read

articles

Event Preview

Event preview of RNA Leaders Europe

Event preview of RNA Leaders Europe

25 February
Read
NextGen Biomed 2026

NextGen Biomed 2026

28 January
Read
RNAi-Based Therapeutics Summit 2026

RNAi-Based Therapeutics Summit 2026

9 January
Read

Industry Insights

Industry Insights: Early 2026 brings clinical progress, regulatory designations, and strategic partnerships in nucleic acid therapeutics

Industry Insights: Early 2026 brings clinical progress, regulatory designations, and strategic partnerships in nucleic acid therapeutics

Jokūbas Leikauskas
9 March
Read
Industry Insights: Advances in enzymatic manufacturing, therapeutic pipelines, and regulatory pathways for nucleic acid therapeutics

Industry Insights: Advances in enzymatic manufacturing, therapeutic pipelines, and regulatory pathways for nucleic acid therapeutics

Jokubas Leikauskas
22 January
Read

Webinars

}